AbbVie Inks $2.7M Deal To End Humira FCA Kickback Battle
AbbVie Inc. has agreed to pay $2.7 million to settle a whistleblower False Claims Act lawsuit accusing it of using unlawful kickbacks to encourage medical providers to prescribe its blockbuster drug...To view the full article, register now.
Already a subscriber? Click here to view full article